1,581 results on '"Iyer, Prasad G."'
Search Results
52. Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma
53. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus
54. Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades
55. Validation and optimization of enhanced volumetric laser endomicroscopy scoring systems for Barrett's esophagus dysplasia
56. Notch Signaling Mediates Differentiation in Barrett’s Esophagus and Promotes Progression to Adenocarcinoma
57. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study
58. A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more
59. Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment tool
60. Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia
61. Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma
62. Risk of progression in Barrett’s esophagus indefinite for dysplasia: a systematic review and meta-analysis
63. Algorithm Training and Testing for a Non-Endoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts
64. What Is the Optimal Surveillance Strategy for Non-dysplastic Barrett’s Esophagus?
65. Advances in Endoscopic Resection in the Management of Esophageal Neoplasia
66. Unsedated Transnasal Endoscopy for Preoperative Examination of Bariatric Patients: a Prospective Study
67. EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses.
68. Innovations in Screening Tools for Barrett’s Esophagus and Esophageal Adenocarcinoma
69. Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development
70. Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory Metastases
71. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study
72. Barrett Esophagus
73. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times
74. Incidental Colonic Ganglioneuroma on Surveillance Colonoscopy
75. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett’s esophagus increases the risk of dysplasia recurrence: meta-analysis
76. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett’s esophagus in patients with GERD symptoms
77. Outcome of endoscopic mucosal resection in Barrett’s esophagus determined by systematic quantification of epithelial glands using volumetric laser endomicroscopy
78. Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone
79. Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening
80. Accuracy of Endoscopic Ultrasound Imaging in Distinguishing Celiac Ganglia From Celiac Lymph Nodes
81. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
82. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
83. Celiac artery mesenteric fat measurement with endosonography (CAMEUS) reliably correlates with obesity and related comorbidities
84. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study
85. A deep learning system for detection of early Barrett's neoplasia: a model development and validation study
86. The Evolving Role of Artificial Intelligence in Gastrointestinal Histopathology: An Update
87. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma
88. Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic
89. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study
90. Detection and surveillance of neoplastic lesions of the esophagus: application of guidelines and techniques
91. Prevalence of Barrett’s Esophagus and Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-Analysis
92. Gastroesophageal Reflux Disease and Complications
93. Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts
94. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus
95. Screening for esophageal squamous cell carcinoma: recent advances
96. Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis
97. Cryotherapy for persistent Barrett’s esophagus after radiofrequency ablation: a systematic review and meta-analysis
98. The Effect of Endoscopic Surveillance in Patients With Barrett’s Esophagus: A Systematic Review and Meta-analysis
99. The Esophageal Epithelial Barrier in Health and Disease
100. Endoscopic eradication therapy for Barrett’s esophagus: Adverse outcomes, patient values, and cost-effectiveness
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.